Atenolol
- Product NDC
- 42708-012
- 11-digit product format
- 427080012
- Labeler code
- 42708
- Product ID
- 42708-012_45b43876-f7b3-e3e8-e063-6394a90ad40a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atenolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- QPharma, Inc.
- Application
- ANDA074056
- Marketing category
- ANDA
- Marketing start
- 1995-02-22
- Substance
- ATENOLOL
- Active strength
- 50 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Atenolol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ATENOLOL | 50 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 50VV3VW0TI |
| Rxcui | 197381 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42708-012-30 | Atenolol | 30 in 1 BOTTLE | TABLET | 30 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42708-012 | ATENOLOL TABLET [QPHARMA, INC.] | 5 | Current NDC, Legacy NDC, 1 package rows | 20241128_70d7a585-7a46-4eac-b2b5-2ac5b98d9882.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42708-012-30 | 42708001230 | 30 TABLET in 1 BOTTLE (42708-012-30) | 30 tablet | 2018-03-14 | 0000-00-00 | Yes | No | Current |